{
  "created_at": "Sat Aug 28 13:2:24 +0000 2021",
  "id_str": "1431598713689026565",
  "full_text": "The Sinopharm vaccine showed three times the death rate from breakthrough infections than the Pfizer-BioNTech vaccine, a Bahrain Study showed https://t.co/jUMcpFeJu2",
  "display_text_range": [
    0,
    165
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/jUMcpFeJu2",
        "expanded_url": "https://on.wsj.com/3joV8nX",
        "display_url": "on.wsj.com/3joV8nX",
        "indices": [
          142,
          165
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 50,
  "favorite_count": 67,
  "possibly_sensitive": false,
  "original_created_at": "Sat Aug 28 12:45:05 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "シノファーム社のワクチンは、ファイザー社・バイオンテック社のワクチンに比べ、画期的な感染症による死亡率が3倍であることがバーレーンの研究で明らかになった https://t.co/jUMcpFeJu2"
    },
    {
      "locale": "zh",
      "full_text": "巴林的一项研究显示，国药集团疫苗的突破性感染死亡率是辉瑞-生物技术公司疫苗的三倍，https://t.co/jUMcpFeJu2。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "巴林的一項研究顯示，國藥集團疫苗的突破性感染死亡率是輝瑞-生物技術公司疫苗的三倍，https://t.co/jUMcpFeJu2。"
    }
  ]
}